Warnings upgraded

Adverse event warnings for the use of fluoroquinolone antibiotics are set to be upgraded, the Therapeutic Goods Administration has revealed. In an alert, released late last week, the TGA says that following a 2019 study on the use of fluoroquinolone antibiotics and risk of aortic aneurysm/dissection, it would update the Product Information (PI) for these